Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BRD-6929 | 849234-64-6 | MFCD16495786 | 99.5% | 351.4 g/mol | C19H17N3O2S | 25 MG
SDP

Catalog No. 5000213687
Encompass_Preferred

BRD-6929 is a potent, selective, brain-penetrant inhibitor of class I histone deacetylases HDAC1 and HDAC2, showing low-nanomolar inhibitory activity and high binding affinity. It is used in preclinical research, including CNS and mood-related behavioral model studies, for target validation and pharmacology characterization.

  • Potent HDAC1 and HDAC2 inhibition (IC50 1 nM and 8 nM).
  • High binding affinity to targets (Ki 0.2 nM and 1.5 nM).
  • Brain-penetrant properties suitable for CNS research.
  • Applicable to mood-related behavioral model studies and target validation.
  • Supplied in small research quantities for preclinical experiments.

Catalog No. 50-002-13687 Supplier Medchemexpress LLC Supplier No. HY10071925MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BRD-6929 is a potent, selective, brain-penetrant inhibitor of class I histone deacetylases HDAC1 and HDAC2, showing low-nanomolar inhibitory activity and high binding affinity. It is used in preclinical research, including CNS and mood-related behavioral model studies, for target validation and pharmacology characterization.

  • Potent HDAC1 and HDAC2 inhibition (IC50 1 nM and 8 nM).
  • High binding affinity to targets (Ki 0.2 nM and 1.5 nM).
  • Brain-penetrant properties suitable for CNS research.
  • Applicable to mood-related behavioral model studies and target validation.
  • Supplied in small research quantities for preclinical experiments.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.